AQR Capital Management - DURATA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
AQR Capital Management ownership history of DURATA THERAPEUTICS INC
ValueSharesWeighting
Q3 2014$534,000
-6.6%
42,100
+25.3%
0.00%
-50.0%
Q2 2014$572,000
+96.6%
33,600
+55.6%
0.00%
+100.0%
Q1 2014$291,00021,6000.00%
Other shareholders
DURATA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Canaan Partners VII LLC 1,902,030$24,118,00041.13%
Aisling Capital LLC 2,030,175$25,740,0004.99%
EAM Investors, LLC 187,925$2,383,0000.48%
Granahan Investment Management 691,283$8,765,0000.27%
Orbimed Advisors 1,785,714$22,643,0000.24%
Lenox Wealth Advisors, LLC 11,000$139,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 76,150$966,0000.02%
PDT Partners, LLC 61,331$778,0000.02%
MAGEE THOMSON INVESTMENT PARTNERS LLC 5,022$63,0000.02%
MASON STREET ADVISORS, LLC 148,533$1,883,0000.02%
View complete list of DURATA THERAPEUTICS INC shareholders